Gig Harbor, WA, United States of America

Jeffrey L Lillard

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Bmg Pharma LLC. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey L Lillard

Introduction

Jeffrey L Lillard is an accomplished inventor based in Gig Harbor, WA (US). He has made significant contributions to the field of medical compositions, particularly focusing on the treatment of mucosal and dermal diseases. His innovative approach combines mineral salts and sulfonic acids to create effective therapeutic solutions.

Latest Patents

Lillard holds a patent for "Mineral salt-sulfonic acid compositions and methods of use." This patent outlines the medical applications of compositions that include a mineral salt and a sulfonic acid. The invention aims to prevent and treat various mucosal and dermal diseases, disorders, or conditions, showcasing Lillard's commitment to advancing medical science.

Career Highlights

Lillard is associated with BMG Pharma S.p.a., where he continues to develop and refine his innovative ideas. His work at the company emphasizes the importance of research and development in creating effective medical treatments.

Collaborations

One of Lillard's notable collaborators is William A Goolsbee. Their partnership highlights the collaborative nature of innovation in the medical field, where diverse expertise can lead to groundbreaking advancements.

Conclusion

Jeffrey L Lillard's contributions to medical compositions demonstrate his dedication to improving health outcomes through innovation. His patent and ongoing work at BMG Pharma S.p.a. reflect the potential of combining scientific knowledge with practical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…